SCHEMBL17178359

SCHEMBL17178359

CCc1cc(C(F)(C(F)(F)F)C(F)(F)F)cc(CC)c1NC(=O)c1cccc(N(CC)C(=O)c2ccc(C#N)cc2)c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.44
RXFP1 Q9HBX9 1/20 0.37
LMNA P02545 3/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
GFER P55789 1/20 0.34
POLB P06746 2/20 0.33
HSD11B1 P28845 1/20 0.33
TXK P42681 1/20 0.33
ITK Q08881 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17178400 0.96 MLYCD (0.42) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL19513092 0.95 MLYCD (0.41) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL17178360 0.95 MLYCD (0.41) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL17178350 0.91 MLYCD (0.43) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL17178329 0.91 MLYCD (0.43) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL18355510 0.90 MLYCD (0.39) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL20233493 0.88 MLYCD (0.41) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL29379234 0.88 MLYCD (0.40) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL15671140 0.88 MLYCD (0.40) MLYCDRXFP1LMNARAB9ASMN1; SMN2
SCHEMBL17178402 0.87 RXFP1 (0.35) MLYCDRXFP1LMNARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170305839-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2017-10-26 US disclosed
US-9718762-B2 Insecticidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2017-08-01 US disclosed
US-20150291510-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2015-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291510-A1 INSECTICIDAL COMPOUNDS ACHE, HDAC6, TUBA3C MLYCD 1808/4885RXFP1 2936/4885LMNA 1725/4885
US-20170305839-A1 INSECTICIDAL COMPOUNDS ACHE, HDAC6, TUBA3C MLYCD 1777/4885RXFP1 3170/4885LMNA 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.